Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6133865

COCCCCCCN1CCC(c2ccc(-c3nnc(N)s3)cc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.40
DRD2 P14416 2/20 0.39
P2RY14 Q15391 1/20 0.39
SIGMAR1 Q99720 3/20 0.38
GPR119 Q8TDV5 1/20 0.38
PAX8 Q06710 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
ADRA1B P35368 1/20 0.38
HRH3 Q9Y5N1 2/20 0.38
DGAT1 O75907 1/20 0.38
SLC18A3 Q16572 1/20 0.37
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
CSNK2A1 P68400 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
RAB9A P51151 1/20 0.37
HTR1A P08908 1/20 0.37
SLC6A2 P23975 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6134403 0.86 USP2 (0.42) DRD2GPR119HRH3CSNK2A2CSNK2B
Trifluoroacetic Acid SCHEMBL6134750 0.86 USP2 (0.42) DRD2GPR119HRH3CSNK2A2CSNK2B
SCHEMBL6134711 0.83 CSNK2A2 (0.51) MAOBP2RY14SIGMAR1HRH3DGAT1
SCHEMBL6134946 0.81 DGAT1 (0.44) MAOBDRD2SIGMAR1ADRA1DADRA1A
Trifluoroacetic Acid SCHEMBL6132856 0.78 RAB9A (0.62) CSNK2A2CSNK2BCSNK2A1LMNAMAPT
Trifluoroacetic Acid SCHEMBL6132415 0.76 SLC18A3 (0.44) GPR119HRH3SLC18A3CSNK2A2CSNK2B
SCHEMBL7174851 0.75 RAB9A (0.45) HRH3LMNAMAPTRAB9AHTR1A
Trifluoroacetic Acid SCHEMBL6135113 0.75 MAPT (0.40) P2RY14ADRA1DADRA1AADRA1BHRH3
SCHEMBL6134617 0.72 HDAC3 (0.46) MAOBDRD2SIGMAR1RAB9AHTR1A
SCHEMBL6135091 0.71 ALDH1A1 (0.49) MAOBDRD2SIGMAR1HRH3SLC18A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed
EP-1366066-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-12-03 EP disclosed
WO-2002072621-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 MAOB 4591/4885DRD2 4545/4885P2RY14 3803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.